Feasibility of constructing tissue microarrays from diagnostic prostate biopsies
Authors:
- 2 May 2007
- journal article
- research article
- Published by Wiley in The Prostate
- Vol. 67 (10) , 1011-1018
Abstract
OBJECTIVES The ability to construct prostate tissue microarrays (TMAs) using prostate needle biopsies could allow high throughput molecular profiling to search for prostate cancer prognostic biomarkers. MATERIALS AND METHODS Diagnostic prostate biopsies from 13 patients (diagnosed 1996–2000) were obtained from the University of North Carolina (UNC) to construct one prostate TMA under uniform conditions. A second prostate TMA was attempted using diagnostic prostate biopsies from 45 patients (diagnosed 2004) obtained from the North Carolina–Louisiana Prostate Cancer Project (PCaP). RESULTS Eleven men had sufficient prostate cancer in their diagnostic prostate biopsy blocks to construct a UNC TMA that yielded six‐micron sections that provided an average of 76% of cores (maximum 99%) to a depth of 360 µm. Diagnostic prostate biopsy blocks from 35 PCaP research subjects were unsuitable for TMA construction as a result of no remaining prostate cancer in 4, insufficient prostate cancer in 9, and insufficient prostate tissue in 22. The PCaP TMA constructed from 10 men yielded an average of 37%, and a maximum of 45%, of cores when sectioned to a depth of 360 µm. CONCLUSIONS TMAs may be constructed from diagnostic prostate biopsies obtained at an academic center under uniform conditions. However, excessive facing of blocks and the large number of re‐cuts ordered by many community pathology laboratories deplete diagnostic prostate biopsy tissue. The experience of a population‐based study of men with newly diagnosed prostate cancer in Louisiana and North Carolina suggests that TMAs may not be constructed using diagnostic prostate biopsies from men diagnosed with prostate cancer throughout the United States. Prostate 67: 1011–1018, 2007.Keywords
This publication has 29 references indexed in Scilit:
- Cancer Statistics, 2007CA: A Cancer Journal for Clinicians, 2007
- The North Carolina–Louisiana Prostate Cancer Project (PCaP): Methods and design of a multidisciplinary population-based cohort study of racial differences in prostate cancer outcomesThe Prostate, 2006
- Prostate Biopsy Tumor Extent but Not Location Predicts Recurrence After Radical Prostatectomy: Results From CaPSUREJournal of Urology, 2006
- Expression of Annexin I, II and VII Proteins in Androgen Stimulated and Recurrent Prostate CancerJournal of Urology, 2004
- Apoptosis levels increase after castration in the CWR22 human prostate cancer xenograftThe Prostate, 2003
- Androgen Receptor Expression and Cellular Proliferation During Transition from Androgen-Dependent to Recurrent Growth after Castration in the CWR22 Prostate Cancer XenograftThe American Journal of Pathology, 2002
- Tissue microarray (TMA) technology: miniaturized pathology archives for high-throughputin situ studiesThe Journal of Pathology, 2001
- Validation of Tissue Microarrays for Immunohistochemical Profiling of Cancer Specimens Using the Example of Human Fibroblastic TumorsThe American Journal of Pathology, 2001
- Tissue microarrays for high-throughput molecular profiling of tumor specimensNature Medicine, 1998
- An Algorithm for Predicting Nonorgan Confined Prostate Cancer Using the Results Obtained from Sextant Core Biopsies with Prostate Specific Antigen LevelJournal of Urology, 1996